Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease [Phase 3]

View source ↗

Summary

Phase 3 trial results update on the safety and efficacy of a modified-release formulation of dexlansoprazole for gastroesophageal reflux disease, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• dexlansoprazole modified-release (dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-03-23